… Read More
LONDON–(BUSINESS WIRE)–Technavio has been monitoring the global engineering services outsourcing market size and it is poised to grow by USD 207.85 billion during 2020-2024, progressing at a CAGR of almost 23% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Accenture, Altair Engineering, Inc., Alten GmbH, Aricent Group, HCL Technologies, Infosys, RLE International Group, TCS, Tech Mahindra Ltd., and Wipro are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining
Multidisciplinary tumor boards are vital to cancer treatment plans, bringing together clinicians from different specialties to guide patient treatment and improve outcomes. However, compiling the relevant data for each case is time-consuming and requires contributions from multiple team members. To optimize the process, researchers at the MU School of Medicine partnered with Roche Diagnostics to evaluate a cloud-based product called NAVIFY® Tumor Board that integrates all relevant clinical data for a tumor board into a single digital dashboard accessible to everyone. During a 16-month clinical study of the dashboard, researchers found NAVIFY Tumor Board significantly reduced the amount of time doctors and nurses across multiple specialties spent preparing for 227 tumor board meetings involving 1866 patient cases.
… Read More
“In addition to saving time, the NAVIFY digital tumor board solution resulted in less variability in preparation time,” said Richard Hammer, MD, professor of pathology at the MU School of Medicine and vice
… Read More
WASHINGTON — The Department of Defense is slated to release its counter-small unmanned aircraft systems strategy next month, bringing an open-system architecture and enterprise approach to the military’s capabilities.The Army-led Joint C-sUAS Office, or JCO, has worked to align current and future counter-drone technologies to support operational requirements at home and abroad, said Maj. Gen. Sean A. Gainey, the program’s director.The increased threat posed by drones, combined with a lack of dependable networked capabilities to counter the unmanned threat, has created a concerning “tactical development” within U.S. Central Command’s area of responsibility, Gainey said, paraphrasing a recent statement made by its commander.Classification of unmanned aircraft systems is divided into five category groups. The defense secretary appointed the Army as the executive agent for counter-small UAS groups one through three, said Col. Richard Wright, the JCO deputy director.These first three categories represent smaller, low-cost drones, whose rapid proliferation can threaten personnel
JOHNS CREEK, GA — Emory Johns Creek Hospital is the first facility in Georgia to offer patients access to the first mobile, advanced digital positron emission tomography (PET) molecular imaging technology.
The uMI 550 is a state-of-the-art digital PET/CT (computed tomography) scanner that delivers faster scan times, reduced radiation doses and enhanced visualization of small lesions with exceptional image quality.
“As a leader in diagnostic imaging, Emory Healthcare is providing patients advanced digital positron emission tomography or PET molecular imaging for individuals in the Northern Arc serviced by Emory Johns Creek Hospital,” says David Schuster, MD, FACR, professor and director, Division of Nuclear Medicine and Molecular Imaging, Emory University School of Medicine.
… Read More
“The technology will facilitate the use of more progressive PET studies, including those for prostate cancer and neuroendocrine tumors.”
The new equipment adds to the ongoing improvements at Emory Johns Creek Hospital and Winship Cancer Institute of Emory